272 related articles for article (PubMed ID: 33400401)
21. Expression profile and prognostic values of Chromobox family members in human glioblastoma.
Li J; Xu Z; Zhou L; Hu K
Aging (Albany NY); 2022 Feb; 14(4):1910-1931. PubMed ID: 35210369
[TBL] [Abstract][Full Text] [Related]
22. CBX2-mediated suppression of SIAH2 triggers WNK1 accumulations to promote glycolysis in hepatocellular carcinoma.
Xu Z; Wu Y; Yang M; Wei H; Pu J
Exp Cell Res; 2023 May; 426(1):113513. PubMed ID: 36780970
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of USP27X by GSK3β maintains the stability and oncogenic functions of CBX2.
Xing Y; Ba-Tu J; Dong C; Cao X; Li B; Jia X; Juan Y; Lv X; Zhang H; Qin N; Han W; Wang D; Qi X; Wang Y; Hao X; Zhang S; Du X; Wang H; Wang M
Cell Death Dis; 2023 Nov; 14(11):782. PubMed ID: 38030604
[TBL] [Abstract][Full Text] [Related]
24. Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value.
Meseure D; Vacher S; Alsibai KD; Nicolas A; Chemlali W; Caly M; Lidereau R; Pasmant E; Callens C; Bieche I
Mol Cancer Res; 2016 Jul; 14(7):623-33. PubMed ID: 27102007
[TBL] [Abstract][Full Text] [Related]
25. Genotranscriptomic meta-analysis of the Polycomb gene CBX2 in human cancers: initial evidence of an oncogenic role.
Clermont PL; Sun L; Crea F; Thu KL; Zhang A; Parolia A; Lam WL; Helgason CD
Br J Cancer; 2014 Oct; 111(8):1663-72. PubMed ID: 25225902
[TBL] [Abstract][Full Text] [Related]
26. Interaction proteomics analysis of polycomb proteins defines distinct PRC1 complexes in mammalian cells.
Vandamme J; Völkel P; Rosnoblet C; Le Faou P; Angrand PO
Mol Cell Proteomics; 2011 Apr; 10(4):M110.002642. PubMed ID: 21282530
[TBL] [Abstract][Full Text] [Related]
27. Nonoverlapping functions of the Polycomb group Cbx family of proteins in embryonic stem cells.
Morey L; Pascual G; Cozzuto L; Roma G; Wutz A; Benitah SA; Di Croce L
Cell Stem Cell; 2012 Jan; 10(1):47-62. PubMed ID: 22226355
[TBL] [Abstract][Full Text] [Related]
28. Polycomb chromobox Cbx2 enhances antiviral innate immunity by promoting Jmjd3-mediated demethylation of H3K27 at the Ifnb promoter.
Sun D; Cao X; Wang C
Protein Cell; 2019 Apr; 10(4):285-294. PubMed ID: 30357595
[TBL] [Abstract][Full Text] [Related]
29. Chromobox homolog 2 protein: A novel biomarker for predicting prognosis and Taxol sensitivity in patients with breast cancer.
Chen WY; Zhang XY; Liu T; Liu Y; Zhao YS; Pang D
Oncol Lett; 2017 Mar; 13(3):1149-1156. PubMed ID: 28454227
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis.
Meng X; Cao R; Liu X; Fu B; Luo L; Jiang M; Wang K; Liu Y; Zhu Q; Yang C; Zhou L
Oncol Lett; 2023 Apr; 25(4):172. PubMed ID: 36970607
[TBL] [Abstract][Full Text] [Related]
31. Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression.
Pickl JM; Tichy D; Kuryshev VY; Tolstov Y; Falkenstein M; Schüler J; Reidenbach D; Hotz-Wagenblatt A; Kristiansen G; Roth W; Hadaschik B; Hohenfellner M; Duensing S; Heckmann D; Sültmann H
Oncotarget; 2016 Sep; 7(37):59589-59603. PubMed ID: 27449098
[TBL] [Abstract][Full Text] [Related]
32. CBX Family Members in Two Major Subtypes of Renal Cell Carcinoma: A Comparative Bioinformatic Analysis.
Grimaldi AM; Affinito O; Salvatore M; Franzese M
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292141
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses.
Zhou H; Xiong Y; Liu Z; Hou S; Zhou T
Cancer Cell Int; 2021 Jul; 21(1):402. PubMed ID: 34321009
[TBL] [Abstract][Full Text] [Related]
34. The paradox of E-cadherin: role in response to hypoxia in the tumor microenvironment and regulation of energy metabolism.
Chu K; Boley KM; Moraes R; Barsky SH; Robertson FM
Oncotarget; 2013 Mar; 4(3):446-62. PubMed ID: 23530113
[TBL] [Abstract][Full Text] [Related]
35. Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal M; Lebeau B; Witcher M
Expert Opin Ther Targets; 2019 Jul; 23(7):565-578. PubMed ID: 31177918
[No Abstract] [Full Text] [Related]
36. Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts.
Meng Q; Zhou Q; Chen X; Chen J
Aging (Albany NY); 2023 Nov; 15(22):12817-12851. PubMed ID: 37980163
[TBL] [Abstract][Full Text] [Related]
37. A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation.
Wang S; Alpsoy A; Sood S; Ordonez-Rubiano SC; Dhiman A; Sun Y; Jiao G; Krusemark CJ; Dykhuizen EC
Chembiochem; 2021 Jul; 22(13):2335-2344. PubMed ID: 33950564
[TBL] [Abstract][Full Text] [Related]
38. Novel chromobox 2 inhibitory peptide decreases tumor progression.
Brubaker LW; Backos DS; Nguyen VT; Reigan P; Yamamoto TM; Woodruff ER; Iwanaga R; Wempe MF; Kumar V; Persenaire C; Watson ZL; Bitler BG
Expert Opin Ther Targets; 2023; 27(4-5):361-371. PubMed ID: 37243607
[TBL] [Abstract][Full Text] [Related]
39. Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment.
Cacciola NA; Sepe R; Forzati F; Federico A; Pellecchia S; Malapelle U; De Stefano A; Rocco D; Fusco A; Pallante P
Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1179-86. PubMed ID: 26216446
[TBL] [Abstract][Full Text] [Related]
40. Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation.
Shinjo K; Yamashita Y; Yamamoto E; Akatsuka S; Uno N; Kamiya A; Niimi K; Sakaguchi Y; Nagasaka T; Takahashi T; Shibata K; Kajiyama H; Kikkawa F; Toyokuni S
Int J Cancer; 2014 Jul; 135(2):308-18. PubMed ID: 24375438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
